S'abonner

Ultrasound-guided selective peripheral nerve block compared with the sub-dissociative dose of ketamine for analgesia in patients with extremity injuries - 03/12/22

Doi : 10.1016/j.ajem.2022.10.020 
Chitta Ranjan Mohanty, MD a, , Jithin Jacob Varghese, MBBS a, Ritesh Panda, MS a, Sangeeta Sahoo, MD a, Tushar Subhadarshan Mishra, MS b, Rakesh Vadakkethil Radhakrishnan, MSc c, Nitish Topno, MD a, Upendra Hansda, MD a, Ijas Muhammed Shaji, MBBS a, Shri Hari Priya Behera, MD aa
a Department of Trauma and Emergency, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India 
b Department of General Surgery, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India 
c College of Nursing, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India 

Corresponding author at: Department of Trauma and Emergency, All India Institute of Medical Science, Bhubaneswar, Odisha 751019, India.Department of Trauma and EmergencyAll India Institute of Medical ScienceBhubaneswarOdisha751019India

Abstract

Study objective

To compare the analgesic efficacy of ultrasound-guided selective peripheral nerve block (PNB) and sub-dissociative dose ketamine (SDK) for management of acute pain in patients with extremity injuries presenting to the emergency department (ED).

Methods

This prospective, open-label randomized clinical trial was conducted in the ED of a tertiary care Institute. The patients were provided with either ultrasound-guided selective PNB or SDK. The primary outcome was a reduction in pain in numerical rating scale (NRS) by at least 3 points without rescue analgesia. The secondary outcomes were the need for rescue analgesia, adverse events, and patient satisfaction on either arm.

Results

A total of 111 patients with isolated traumatic extremity injuries were included in the final analysis. The NRS score was significantly lower in the PNB group compared to the SDK group at 30, 60,120, 180-, and 240-min post-intervention [group ∼ time interaction, F (5, 647) = 21.53, p ≤ 0.001]. All the patients in the PNB group exhibited primary outcome (NRS ≥3 reductions) at 30 min post-intervention compared with 36 (65%) in the SDK group [−1.02(−1.422,0.622)]. Rescue analgesia was required in 10 (18%) patients in the SDK group compared to none in the PNB group [0.663(0.277,1.050)]. The decrease in NRS score from baseline at 30 min was significantly higher in PNB groups compared to the SDK group [−2.166(−2.640, −1.692)]. The most common side effect reported in the SDK group was dizziness 35(64%), followed by nausea 15(27%). None of the patients in the PNB group reported any complications. Patient satisfaction was higher in the PNB group than SDK group.

Conclusion

The study provides evidence that ultrasound-guided PNB is superior to SDK in terms of its analgesic efficacy in the management of acute pain due to extremity injuries and is associated with higher patient satisfaction. The need for rescue analgesia was significantly less in the PNB group. SDK was associated with a high incidence of dizziness and nausea.

Le texte complet de cet article est disponible en PDF.

Keywords : Sub-dissociate dose, Ketamine, Peripheral nerve block, Extremity injuries


Plan


© 2022  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 63

P. 94-101 - janvier 2023 Retour au numéro
Article précédent Article précédent
  • Non-rebreather mask and low-flow nasal cannula vs high-flow nasal cannula in severe COVID−19 pneumonia in the emergency department
  • Muhammad Khidir Mohd Kamil, Khadijah Poh Yuen Yoong, Abdul Muhaimin Noor Azhar, Aida Bustam, Ahmad Hariz Abdullah, Mohd Hafyzuddin Md Yusuf, Aliyah Zambri, Ahmad Zulkarnain Ahmad Zahedi, Hidayah Shafie
| Article suivant Article suivant
  • Evaluation of respiratory function in healthcare workers wearing face masks during the COVID-19 pandemic
  • İsmail Kıvanç Cebecioğlu, Erdal Demirtaş, Yusuf Kenan Tekin, İlhan Korkmaz

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.